ISIvo Schmerold

Ivo Schmerold

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ivo Schmerold has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Romeo Teodor Cristina

    Department of Pharmacology and Pharmacy, University of Life Sciences “King Mihai I” from Timișoara, Calea Aradului 119, 300645 Timișoara, Romania

    2 shared publications
  • Agnes Dadak

    Institute of Pharmacology and Toxicology, Clinical Pharmacology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria

    1 shared publication
  • Diana Obistioiu

    Faculty of Agriculture, University of Life Sciences “King Mihai I” from Timisoara, Calea Aradului 119, 300645 Timisoara, Romania

    1 shared publication
  • E. Tyden

    Division of Parasitology, Department of Biomedical Science and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden

    1 shared publication
  • H. Linden

    Veddesta Business Center, EUFEPS, Järfälla (Stockholm), Sweden

    1 shared publication
  • Hans Niedermüller

    Institute of Physiology and Ludwig Boltzmann Institute for Aging Research, Department of Natural Sciences, Veterinary University of Vienna, Vienna, Austria

    1 shared publication

Latest Publications

  • Top Cited Papers
    Open Access

    European regulations on the use of antibiotics in veterinary medicine

    by Ivo Schmerold, Inge van Geijlswijk, Ronette Gehring


  • Open Access

    Network on veterinary medicines initiated by the European Federation For Pharmaceutical Sciences

    by J. P. Mochel, E. Tyden, K. Hellmann, J. C. Vendrig, S. Şenel, L. Dencker, R. T. Cristina, H. Linden, I. Schmerold

    The European Federation for Pharmaceutical Sciences (EUFEPS) was founded 25 years ago by more than 20 national pharmaceutical societies and faculty members. As a pan‐European organization, it brings together pharmaceutical societies as well as academic, industrial and regulatory scientists engaged in drug research and development, drug regulation and education of professionals working in these fields. EUFEPS represents pharmaceutical sciences in Europe and is recognized as such by both the European Commission and the European Medicines Agency. EUFEPS cooperates with the European Federation of Pharmaceutical Industries and other European organizations and maintains global connections with agencies such as the US Food and Drug Administration and the American Association of Pharmaceutical Scientists. EUFEPS has established specified networks forming the basis of its activities. The creation of a Network on Veterinary Medicines is prompted by the manifold problems resulting from the use of veterinary drugs and its inherent interconnections with human medicine, environmental and public health. A long‐term goal of this initiative was to expand the spectrum of available therapeutics for use in animals, including the development of innovative delivery systems.


  • Open Access

    Chemical characterization by GC-MS and in vitro activity against Candida albicans of volatile fractions prepared from Artemisia dracunculus, Artemisia abrotanum, Artemisia absinthium and Artemisia vulgaris

    by Diana Obistioiu, Romeo T Cristina, Ivo Schmerold, Remigius Chizzola, Klaus Stolze, Ileana Nichita, Viorica Chiurciu

    Background: A large number of essential oils is reported to have significant activity againstCandida albicans. But the different chemical composition influences the degree of their activity. The intention of this study was to investigate the chemical composition and the activity againstCandida albicansof volatile oils obtained fromArtemisia dracunculus,A. abrotanum,A. absinthiumandA. vulgaris(Asteraceae). The aim of the study was to identify new chemical compounds that have effect againstC. albicans.The essential oils were obtained by hydrodistillation or extraction with dichloromethane (a new procedure we developed trying to obtain better, more separated compounds) from air dried above ground plant material and analyzed by GC-MS. Additionally commercial essential oils from the same species were tested. TheCandida albicansinhibition studies were carried out by the paper disc diffusion method.Results: The essential oils shared common components but presented differences in composition and showed variable antifungal activity. Davanone and derivatives thereof, compounds with silphiperfolane skeleton, estragole, davanone oil, β-thujone, sabinyl acetate, herniarin, cis-chrysanthenyl acetate, 1,8-cineol, and terpineol were the main components ofArtemisiavolatiles.Conclusions: Among the volatile fractions tested those fromA. abrotanumcontaining davanone or silphiperfolane derivatives showed the highest antifungal activity. Thein vitrotests revealed that theArtemisiaoils are promising candidates for further research to develop novel anti-candida drugs.


  • Low dose magnetic fields do not cause oxidative DNA damage in human placental cotyledons in vitro

    by Maciej Lopucki, Ivo Schmerold, Agnes Dadak, Henryk Wiktor, Hans Niedermüller, Marta Kankofer

    The biological impact of low dose magnetic fields generated by electric appliances present in the human environment is still uncertain. In this study, human placentas served as a model tissue for the evaluation of the potential effect of oscillating low intensity magnetic fields on the concentration of 8-hydroxy-2′-deoxyguanosine (8-OH-dG) in cellular DNA. Cotyledons were dissected from placentas obtained immediately after physiological labours and exposed to magnetic fields (groups MF A, 2 mT, 50 Hz and MF B, 5 mT, 50 Hz) or sham exposed (group C) during an in vitro perfusion of 3 h. Cellular DNA was isolated, hydrolyzed and analyzed by HPLC. Native nucleosides were monitored at 254 nm and 8-OH-dG by electrochemical detection. Results were expressed as μmol 8-OH-dG/mol deoxyguanosine (dG). The concentrations of 8-OH-dG in group C, MF A and MF B were 28.45±15.27 μmol/mol dG, 62.80±31.91 μmol/mol dG, and 27.49±14.23 μmol/mol dG, respectively, demonstrating no significant difference between the groups. The results suggest that placental tissues possess a capacity to protect DNA against oxidative alterations by magnetic field of intensities previously shown to produce radical mediated DNA damage in rat brain cells in vivo and imbalances in electrolyte release of cotyledons under in vitro conditions.